Skip to content

Comparative, non-randomized study for keratosis pilaris (A condition that causes rough patches and small, acne-like bumps on the skin)

Comparative study of efficacy of 2940 nm fractional Erb:yag vs 1064nm Nd:yag (FRAC3) vs both in the treatment of keratosis pilaris

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2022/12/048073
Enrollment
50
Registered
2022-12-13
Start date
Unknown
Completion date
Unknown
Last updated
2024-03-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L739- Follicular disorder, unspecified Health Condition 2: 8- Other Procedures

Interventions

Intervention1: Fractional Erbium : YAG 2940nm: Parameters - 4-6J/cm2, spot size 4mm, frequency 8Hz, single pass. Control Intervention1: FRAC3 Nd: YAG 1064nm: Parameters - 25J/cm2, pulse width 1.6msec,

Sponsors

None listed

Eligibility

Inclusion criteria

Inclusion criteria: Age >18 years presenting with KP lesions

Exclusion criteria

Exclusion criteria: •Patients on topical treatment (steroids, keratolytics, retinoids) 1 month before the laser treatment •Patients who received laser for the treatment of keratosis Pilaris in the last 6 months. •History of autoimmune disease •History of Keloid & hypertrophic scar. •Pregnant or lactating women.

Design outcomes

Primary

MeasureTime frame
To compare the effectiveness of Fractional Erbium: YAG laser, FRAC3 Nd: YAG laser and combination of both in the improvement of skin roughness, reduction of pigmentation and redness.Timepoint: Baseline(week 0), week 4, week8, week 12 and week 16

Secondary

MeasureTime frame
To assess the patient satisfaction regarding the treatment response with respect to Fractional Erbium : YAG , FRAC3 Nd: YAG and combination of both lasers.Timepoint: baseline(week 0) and week 16

Countries

India

Contacts

Public ContactDr Madura C

CUTIS Academy of Cutaneous Sciences

maduradr@gmail.com9632741998

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026